An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could eventually be an alternative or add-on to popular GLP-1 medications.
Več na: https://www.wired.com/story/new-obesity-pill-may-burn-fat-without-suppressing-appetite/